Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing depression in pregnancy.

A Buist1

  • 1Austin Repatriation Medical Centre, Victoria.

Australian Family Physician
|July 29, 2000
PubMed
Summary

Treating depression during pregnancy requires careful consideration of medication risks and benefits. While antidepressants show no clear teratogenic effects, mood stabilizers should be avoided. Effective management prioritizes maternal and fetal well-being.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of public mother-baby psychiatric units in Australia: similarities, strengths and recommendations.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2018
Same author

The impact of education, country, race and ethnicity on the self-report of postpartum depression using the Edinburgh Postnatal Depression Scale.

Psychological medicine·2016
Same author

Development of a Scalable, High-Throughput-Compatible Assay to Detect Tau Aggregates Using iPSC-Derived Cortical Neurons Maintained in a Three-Dimensional Culture Format.

Journal of biomolecular screening·2016
Same author

Health services utilization of women following a traumatic birth.

Archives of women's mental health·2015
Same author

PRIME: impact of previous mental health problems on health-related quality of life in women with childbirth trauma.

Archives of women's mental health·2013
Same author

Postpartum psychiatric disorders : guidelines for management.

CNS drugs·2013

Area of Science:

  • Perinatal mental health
  • Pharmacology in pregnancy
  • General practice medicine

Background:

  • Increasing recognition of depression in the general population.
  • Depression during pregnancy poses risks to both mother and fetus.
  • The welfare of the fetus and child are paramount considerations.

Purpose of the Study:

  • To examine management challenges for general practitioners regarding depression in pregnant patients.
  • To discuss teratogenicity and medication effects during pregnancy, labor, and breastfeeding.
  • To evaluate the risks associated with untreated depression in pregnancy.

Main Methods:

  • Review of clinical management dilemmas.
  • Discussion of pharmacological risks and benefits.
  • Consideration of treatment outcomes for mother and child.

Main Results:

  • Antidepressants appear to have no significant teratogenic effects, though subtle impacts cannot be ruled out.
  • Mood stabilizers carry a higher risk of teratogenicity and are generally not recommended during pregnancy.
  • Minimizing antidepressant dosage and reducing it towards term is advised when medication is necessary.

Conclusions:

  • Collaborative management involving the woman and her partner is crucial for informed decision-making.
  • Ongoing monitoring and treatment are essential throughout pregnancy.
  • Failure to adequately treat maternal depression can have serious consequences for both mother and child.

Related Experiment Videos